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Abstract Centenarians are the best example of
extreme human longevity, and they represent a
selected population in which the appearance of major
age-related diseases, such as cancer, and cardiovas-
cular diseases among others, has been consistently
delayed or escaped. The study of the long-lived
individual genetic profile has the purpose to possibly
identify the genes and the allelic variations influenc-
ing extended life expectancy, hence considering them
as biomarkers of age-related diseases onset and
development. The present study shows no significant
differences between allelic variations of ABO blood
groups among a group of centenarians from Western
Sicily.
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Introduction
In order to understand one of the possible bases of
longevity we have taken centenarians as a model. In
Europe, centenarians account for 1/10000 inhabitants
although there are some places where the ratio is
lower like in some places of Ogliastra (Sardinia) and
other places in the Monti Sicani (Sicily). These
subjects represent a segment of the population
surviving to extreme old age and age-related diseases
such as cancer and cardiovascular diseases. We
believe that learning from their experience is the
best way to understand how they beat the odds of
environmental and biological obstacles to which most
humans fall prey (Capri et al. 2008; Franceschi et al.
2008).
Undeniably, the increase of the human life span is
not simply due to the improved economic, cultural
conditions and social/health cares, but also to the
synergy among those and the genetic variability
present in human populations. These factors are the
target of a variety of studies, aimed to identify the
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genes and polymorphic variants, which could have a
fundamental role in the attainment of extreme
longevity in different countries characterized by
different genetic pool, cultural habits and survival
probability. Thus, the scenario of human longevity is
getting more and more complex, as demographic
conditions change and scientific knowledge increases
raising new insights into this puzzling and sometimes
contradicting topic (Capri et al. 2008; Franceschi
et al. 2008; Candore et al. 2010a).
In this study we tried to attempt a possible
connection between the histo-blood group ABO and
life expectancy, ABO group is the major human
alloantigen system which involves three carbohydrate
antigens (ABH) which has been studied by molecular
biology applications, since 1990. Individuals who are
A, B and AB express glycosyltransferase activities
converting the H antigen into A or B antigens,
whereas O(H) individuals lack such activity. The
gene encodes a glycosyltransferase, which moves
N-acetyl D-galactosamine (group A) or D-galactose
(group B) to the nonreducing ends of glycans on
glycoproteins and glycolipids. If a person shows
neither A nor B transferase, he/she belongs to the
group O while the expression of both transferases
indicate AB group. The genes for the A and B
transferase are located on the long arm of chromo-
some 9 (9q34). They consist of seven exons with a
total length of 1065 base pairs. The most significant
mutations are located on exons 6 and 7 that contain
77% of the full coding regions. There are 5 main
alleles described in literature: A1, A2, B1, O1 and
O2; there are many variations and subgroups (Dan-
iels, 2009).
Historically, the ABO phenotype was one of the
first marker to be typed both for studying disease
(Aird et al. 1953, 1954) and ageing (Murray, 1961).
In the present paper, we attempted to find any
difference between allelic variations of ABO blood
groups among a group of centenarians from Western
Sicily and a population represented by healthy blood
donors.
Materials and methods
We have genotyped 38 centenarians (15 males and 23
females, age range 100–107) and 59 healthy controls
(44 males and 15 females, age range 45–65). The
studied population came from Palermo surrounding
municipalities in Western Sicily, Italy (Bu¨rkle et al.
2007; Candore et al. 2010b). The age of Sicilian
centenarians was verified by archival records at the
municipal offices and\or church registries. We paid
particular attention to the concordance between
reported age and personal chronologies (age of
marriage and of military service for men, age of first
and last pregnancy for women, age of children,
among others). This group did not have any cardiac
risk factors or major age-related diseases (e.g.,
coronary heart disease, severe cognitive impairment,
severe physical impairment, clinically evident cancer,
or renal insufficiency), although some had decreased
auditory and visual acuity, as would be expected. The
healthy control group was recruited amongst healthy
blood donors (from the same Palermo surrounding
municipalities) who were judged to be in good health
on the basis of their clinical history and blood tests
(complete blood cell count, erythrocyte sedimenta-
tion rate, glucose, urea nitrogen, creatinine, electro-
lytes, C-reactive protein, liver function tests, iron,
proteins, cholesterol, triglycerides). Since immigra-
tion and intermarriage have historically been rare, the
Sicilian ethnicity of all participants was established if
all four grandparents were born in Western Sicily.
The study was approved by the University Hospital
Ethics Committee, and written informed consent was
obtained from all participants.
All samples were genotyped with BAGene ABO-
TYPE (Formedic, Mila, Italy). BAGene ready-to-use
PCR-SSP kits allows the determination of the main
alleles as well as the common subgroups. Allele
frequencies were evaluated by gene count, and 2 9 2
tables were constructed to determine the statistical
significance (chi-squared test with Yates correction)
of differences in allele frequency for the ABO
variants between centenarians and controls. The
P values obtained were multiplied for the number
of alleles under study (Bonferroni correction). The
data were tested for the goodness of fit between the
observed and expected genotype values and their fit
to Hardy–Weinberg Equilibrium (HWE).
Results
The aim of our study was to identify the allelic
variations in the ABO group which could be
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associated to a possible increase in life span. Table 1
shows the ABO alleles frequencies in 59 healthy
controls and 38 centenarians. The frequencies of the
genes under investigation were consistent with those
predicted by the HWE. The results indicate that
centenarians show a frequency of the A1 allele of
around 39.5%, higher than the value observed in
controls (30.5%) (Table 1).
This not significant increase has been compensated
by a decrease in the other ABO allele frequencies,
which were lower in comparison to those observed in
controls (due to the small size of the samples data
were not analysed according to the gender). In
controls, the frequencies of major ABO alleles are
not significantly different from those observed in the
Sicilian healthy blood donors on the whole (The most
common allele A1 shows a percentage of 30.5 in
control population against 39.5 in centenarians. The
percentage of B1 is 18.6 in control population against
13 in centenarians while the most common allele O1
shows a percentage of 88.1 in control population
against 84.2 in centenarians).
Discussion
More than 65 years ago, it was postulated that
individuals belonging to the different blood groups
were not equally viable and it was suggested to study
in any detail the blood group distributions in patients
suffering from a wide variety of diseases (Ford 1945).
Accordingly, several studies have shown significant
association between ABO alleles and different types
of disease although with contrasting results (Garratty,
2000; Anstee, 2010). Different problems like small
sample sizes, the potential for population stratifica-
tion, and modest statistical significance have headed
to suspicion regarding the results. Nonetheless, some
associations appear striking, including an increased
risk of severe Plasmodium falciparum malaria in
those with non-O alleles. (Fry et al. 2008; Anstee,
2010). Furthermore, numerous studies showed a
strong association of non-O blood group with arterial
and venous thromboembolism due to the presence, in
A/B subjects, of high levels of von Willebrand Factor
and Factor VIII (Anstee, 2010). There are other
examples of infectious diseases in which the severity
of infection can be directly linked to ABO phenotype.
Patients of group O were more susceptible to severe
infections by Vibrio cholerae than non-O patients
(Harris et al. 2005) and in an outbreak of gastroin-
testinal infections caused by Escherichia coli O157 in
Scotland in 1996, 87.5% of patients who died were
group O (Blackwell et al. 2002).
On the other hand, in a prospective study per-
formed on Scandinavian blood donors, it was clearly
established that blood group A was associated with a
higher risk of cancer of stomach, whereas blood
group B was associated with peptic ulcers (Edgren
et al. 2010). A possible explanations might be
linked to different susceptibilities and immunologic
responses to H. pylory.
Without any doubt, human longevity appears to be
inextricably linked to optimal functioning of the
immune system, suggesting that specific genetic
determinants may reside in loci that regulate the
Table 1 ABO Genotypic results in healthy people and centenarians
Alleles Controls n = 59 Centenarians n = 38
Total Women Men Total Women Men
A1 18 (30.5%) 6 (10.2%) 12 (20.3%) 15 (39.5%) 9 (23.7%) 6 (15.8%)
A1v 1 (1.7%) 1 (1.7%) – – – –
Ax 1 (1.7%) 1 (1.7%) – – – –
A2 2 (3.4%) 1 (1.7%) 1 (1.7%) 1 (2.6%) 1 (2.6%) –
B1 11 (18.6%) 1 (1.7%) 10 (16.9%) 5 (13%) 2 (5.2%) 3 (7.9%)
B3 1 (1.7%) – 1 (1.7%) – – –
O1 52 (88.1%) 13 (22%) 39 (66.1%) 32 (84.2%) 21 (55.3%) 11 (28.9%)
O1v 29 (49.1%) 5 (8.5%) 24 (40.7%) 20 (52.6%) 13 (34.2%) 7 (18.4%)
O2 2 (3.4%) 1 (1.7%) 1 (1.7%) 3 (7.9%) – 3 (7.9%)
No significant differences were observed comparing data of centenarians with those of controls
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immune response to infectious diseases (Candore
et al. 2003). Additionally, in our previous work,
concerning human leukocyte antigen (HLA) and
killer cell immunoglobulin-like receptor (KIR), we
suggested that the HLA/KIR/longevity associations
are population specific, since these are heavily
affected by the population-specific genetic and envi-
ronmental history (Listı` et al. 2010).
Concerning ABO blood group, there are only four
reports suggesting a possible association between
ABO blood groups and ageing/longevity features,
among those only one performed on centenarians and
none performed by molecular methods. In the first
one, a significant increase of A blood type was
observed in the healthy elderly male population over
64 years of age from UK (Murray, 1961). In a study
carried out on a small sample of very longevous
Turkish population, no association was found (Stur-
geon et al. 1969); however, the validity of age claims
was very questionable because birth certificates were
not available. In a survey of 269 Japanese centenar-
ians, B allele was shown to be associated with
longevity (Shimizu et al. 2004). However, in another
study involving patients and healthy people from
North Carolina (USA), B allele was not a marker for
longevity but rather a marker for earlier death
(Brecher and Hay, 2011). So, it seems that the
association between ABO group and longevity are
influenced by population-specific genetic and envi-
ronmental history as for HLA and KIR antigens.
Our pilot study shows a not-significant increase of
A1 allele in Sicilian centenarians. It is interesting to
note that levels of serum soluble E-selectin, inflam-
matory marker of several diseases, including cardio-
vascular ones, are higher in O/O individuals, whereas
a single nucleotide polymorphism in A1 allele is
associated with low levels of these inflammatory
markers (Paterson et al. 2009). Caruso’s group has
performed several studies showing that inflammatory
gene variants, responsible for a low inflammatory
response or a high anti-inflammatory response are
associated with longevity, avoiding or delaying the
onset of cardiovascular disease (Capri et al. 2008;
Candore et al. 2010a,b). So, our results, that need to
be confirmed in a larger sample of centenarians, are
in line with previous statement, because the presence
of A1 allele in centenarians might be linked to the
lower levels serum soluble E-selectin of this blood
group. Lastly, any gene-longevity study should be
always analyzed after gender stratification, in the
current study this has not been done because of the
small sample size.
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